Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1955 1
1962 1
1964 1
1965 1
1975 10
1976 6
1977 9
1978 12
1979 18
1980 34
1981 53
1982 109
1983 132
1984 197
1985 283
1986 390
1987 462
1988 538
1989 741
1990 761
1991 877
1992 963
1993 1064
1994 1346
1995 1372
1996 1566
1997 1721
1998 1808
1999 1867
2000 2171
2001 2206
2002 2413
2003 2554
2004 2983
2005 3394
2006 3720
2007 3908
2008 4273
2009 4705
2010 5392
2011 5790
2012 6582
2013 7079
2014 7811
2015 8282
2016 7810
2017 7679
2018 9110
2019 9884
2020 11239
2021 5747
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

126,207 results
Results by year
Filters applied: . Clear all
Page 1
Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.
Hane FT, Robinson M, Lee BY, Bai O, Leonenko Z, Albert MS. Hane FT, et al. J Alzheimers Dis. 2017;57(3):645-665. doi: 10.3233/JAD-160907. J Alzheimers Dis. 2017. PMID: 28269772 Free PMC article. Review.
The field of Alzheimer's disease (AD) research has grown exponentially over the past few decades, especially since the isolation and identification of amyloid-beta from postmortem examination of the brains of AD patients. Recently, the Journal of Al
The field of Alzheimer's disease (AD) research has grown exponentially over the past few decades, especially sin …
Clinical Research on Alzheimer's Disease: Progress and Perspectives.
Sun BL, Li WW, Zhu C, Jin WS, Zeng F, Liu YH, Bu XL, Zhu J, Yao XQ, Wang YJ. Sun BL, et al. Neurosci Bull. 2018 Dec;34(6):1111-1118. doi: 10.1007/s12264-018-0249-z. Epub 2018 Jun 28. Neurosci Bull. 2018. PMID: 29956105 Free PMC article. Review.
Alzheimer's disease (AD), the most common type of dementia, is becoming a major challenge for global health and social care. However, the current understanding of AD pathogenesis is limited, and no early diagnosis and disease-modifying therapy are curr
Alzheimer's disease (AD), the most common type of dementia, is becoming a major challenge for global health and social
The Alzheimer Precision Medicine Initiative.
Hampel H, Vergallo A, Perry G, Lista S; Alzheimer Precision Medicine Initiative (APMI). Hampel H, et al. J Alzheimers Dis. 2019;68(1):1-24. doi: 10.3233/JAD-181121. J Alzheimers Dis. 2019. PMID: 30814352 Review.
PM is defining which therapeutic approach will be the most effective for a specific individual, at a determined disease stage, across multiple medical research fields, including neuroscience, neurology and psychiatry. The launch of the Alzheimer Precision Med …
PM is defining which therapeutic approach will be the most effective for a specific individual, at a determined disease stage, across …
Effects of Physical Exercise on Alzheimer's Disease Biomarkers: A Systematic Review of Intervention Studies.
Frederiksen KS, Gjerum L, Waldemar G, Hasselbalch SG. Frederiksen KS, et al. J Alzheimers Dis. 2018;61(1):359-372. doi: 10.3233/JAD-170567. J Alzheimers Dis. 2018. PMID: 29154278 Review.
Physical exercise may be an important adjunct to pharmacological treatment of Alzheimer's disease (AD). Animal studies indicate that exercise may be disease modifying through several mechanisms including reduction of AD pathology. ...
Physical exercise may be an important adjunct to pharmacological treatment of Alzheimer's disease (AD). Animal studies …
Photobiomodulation for Alzheimer's Disease: Translating Basic Research to Clinical Application.
Enengl J, Hamblin MR, Dungel P. Enengl J, et al. J Alzheimers Dis. 2020;75(4):1073-1082. doi: 10.3233/JAD-191210. J Alzheimers Dis. 2020. PMID: 32390621 Free PMC article. Review.
This review covers the literature on photobiomodulation therapy as a novel approach to prevent and treat Alzheimer's disease, aiming to bridge that gap by gathering together the terms and technical specifications into a single concise suggestion for a treatme …
This review covers the literature on photobiomodulation therapy as a novel approach to prevent and treat Alzheimer's diseas
The "rights" of precision drug development for Alzheimer's disease.
Cummings J, Feldman HH, Scheltens P. Cummings J, et al. Alzheimers Res Ther. 2019 Aug 31;11(1):76. doi: 10.1186/s13195-019-0529-5. Alzheimers Res Ther. 2019. PMID: 31470905 Free PMC article. Review.
There is a high rate of failure in Alzheimer's disease (AD) drug development with 99% of trials showing no drug-placebo difference. ...Severity of disease and drug mechanism both have a role in defining the right participant. ...
There is a high rate of failure in Alzheimer's disease (AD) drug development with 99% of trials showing no drug-placebo …
2016 Alzheimer's disease facts and figures.
Alzheimer's Association. Alzheimer's Association. Alzheimers Dement. 2016 Apr;12(4):459-509. doi: 10.1016/j.jalz.2016.03.001. Alzheimers Dement. 2016. PMID: 27570871
The actual number of deaths to which Alzheimer's disease contributes is likely much larger than the number of deaths from Alzheimer's disease recorded on death certificates. In 2016, an estimated 700,000 Americans age 65 years will die wi …
The actual number of deaths to which Alzheimer's disease contributes is likely much larger than the number of deaths fr …
Sex and gender in Alzheimer's disease - Does it matter?
Mielke MM, Ferretti MT, Iulita MF, Hayden K, Khachaturian AS. Mielke MM, et al. Alzheimers Dement. 2018 Sep;14(9):1101-1103. doi: 10.1016/j.jalz.2018.08.003. Alzheimers Dement. 2018. PMID: 30196887 No abstract available.
Advancing Alzheimer's research: A review of big data promises.
Zhang R, Simon G, Yu F. Zhang R, et al. Int J Med Inform. 2017 Oct;106:48-56. doi: 10.1016/j.ijmedinf.2017.07.002. Epub 2017 Jul 24. Int J Med Inform. 2017. PMID: 28870383 Free PMC article. Review.
OBJECTIVE: To review the current state of science using big data to advance Alzheimer's disease (AD) research and practice. In particular, we analyzed the types of research foci addressed, corresponding methods employed and study findings report …
OBJECTIVE: To review the current state of science using big data to advance Alzheimer's disease (AD) research an …
126,207 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page